Endospan reports encouraging one-year results for aortic arch stent-graft study

Endospan reports encouraging one-year results for aortic arch stent-graft study

Study shows low stroke, mortality rates in high-risk patients treated with endovascular arch device

Endospan announces one-year data from TRIOMPHE IDE study

Nexus system Endospan today announced the one-year results of its TRIOMPHE investigational device exemption (IDE) study evaluating the Nexus aortic arch stent graft system. The data were presented at the Society of Thoracic Surgeons (STS) annual meeting (29 January–1 February, New Orleans, USA). TRIOMPHE is a prospective, multicentre, three-arm trial designed to assess the safety and effectiveness of the Nexus system in patients with aortic arch…